Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 9/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.45 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12869912 | 1.00 | LTA4H (0.54) | LTA4HALDH1A1KDM4ELMNAMAPK1 | |
| SCHEMBL124386 | 0.89 | ALDH1A1 (0.54) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 | |
| SCHEMBL124384 | 0.89 | ALDH1A1 (0.54) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 | |
| SCHEMBL1918223 | 0.89 | ALDH1A1 (0.54) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 | |
| SCHEMBL17534790 | 0.88 | LTA4H (0.60) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 | |
| SCHEMBL17446697 | 0.88 | LTA4H (0.60) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 | |
| Acetic Acid SCHEMBL27602909 | 0.88 | ALDH1A1 (0.51) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 | |
| SCHEMBL15896070 | 0.88 | LTA4H (0.60) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL5274239 | 0.88 | ALDH1A1 (0.53) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL19839422 | 0.88 | ALDH1A1 (0.53) | LTA4HALDH1A1LMNAMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230138393-A1 | LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| WO-2022133588-A1 | RNA VIRUS INHIBITOR COMPOUNDS AND USES THEREOF | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2022-06-30 | — | — | WO | disclosed |
| US-9556119-B2 | Process for preparing desmosine, isodesmosine, and derivatives thereof | SOPHIA SCHOOL CORPORATION (JP) | 2017-01-31 | — | — | US | disclosed |
| US-20150376127-A1 | PROCESS FOR PREPARING DESMOSINE, ISODESMOSINE, AND DERIVATIVES THEREOF | SOPHIA SCHOOL CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230138393-A1 | LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF | BCAT2, BCAT1, AARS1 | LTA4H 1293/4885ALDH1A1 3622/4885KDM4E 2001/4885 |
| US-20150376127-A1 | PROCESS FOR PREPARING DESMOSINE, ISODESMOSINE, AND DERIVATIVES THEREOF | SI, SMS, SRM | LTA4H 3935/4885ALDH1A1 1947/4885KDM4E 189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.